Cell Line : KS-1[HUMANKRUKENBERGTUMOUR]
Cellosaurus Index : CVCL_D284
Cellosaurus ID : KS-1[HUMANKRUKENBERGTUMOUR]
CTRP2 Name
: KS1
GDSC1 Name
, GDSC2 Name
: KS-1
Cancer Type : central_nervous_system
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| KS-1[HUMANKRUKENBERGTUMOUR] | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | 123138 | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | 123829 | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | 150412 | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | 5-azacytidine | GDSC2 | 0.0200 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | 50869 | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | 615590 | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | 630600 | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | 667880 | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | 720427 | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | 729189 | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | 741909 | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | 743380 | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | 765771 | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | 776928 | GDSC2 | 0.0300 | 30.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | A-366 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | A-443654 | GDSC1 | 0.0040 | 1.0240 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | A-770041 | GDSC1 | 0.0200 | 5.1200 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | ABT737 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Acetalax | GDSC2 | 0.0300 | 30.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Afatinib | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AGK-2 | GDSC2 | 0.0040 | 4.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Alisertib | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Alpelisib | GDSC2 | 0.0050 | 5.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | alpha-lipoic acid | GDSC2 | 0.1211 | 121.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | ascorbate (vitamin C) | GDSC2 | 2.0011 | 2000.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AT13148 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AT7867 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Axitinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZ628 | GDSC1 | 0.0156 | 4.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD1208 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD1332 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD2014 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD4547 | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD5153 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD5438 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD5991 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD6482 | GDSC1 | 0.0195 | 5.1200 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD7762 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD8055 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BDF00022089a | GDSC2 | 0.0050 | 5.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BDILV000379a | GDSC2 | 0.0050 | 5.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BDOCA000347a | GDSC2 | 0.0020 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BDP-00009066 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Belinostat | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BEN | GDSC2 | 0.0300 | 30.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Bexarotene | GDSC1 | 0.0312 | 8.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BI-2536 | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BIBR-1532 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Bicalutamide | GDSC1 | 0.0040 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Bleomycin | GDSC1,GDSC2 | 0.0020 | 64.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Bleomycin (50 uM) | GDSC1,GDSC2 | 0.0400 | 50.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BMS-345541 | GDSC1,GDSC2 | 0.0100 | 16.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BMS-509744 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BMS-536924 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BMS-754807 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Bortezomib | GDSC1,GDSC2 | 0.0000 | 0.0200 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Bosutinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BPD-00008900 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Bromosporine | GDSC2 | 0.0020 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | BX795 | GDSC1 | 0.0195 | 5.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Cabozantinib | GDSC1 | 0.0200 | 5.1200 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Carmustine | GDSC2 | 0.0300 | 30.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CCT-018159 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CDK9_5038 | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CDK9_5576 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CGP-082996 | GDSC1 | 0.0200 | 5.1200 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CGP-60474 | GDSC1 | 0.0010 | 0.2560 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CHIR-99021 | GDSC1 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Cisplatin | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CMK | GDSC1 | 0.0156 | 4.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CPI-637 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Crizotinib | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CT7033-2 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Cyclopamine | GDSC1 | 0.0625 | 16.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Cytarabine | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Dacarbazine | GDSC2 | 0.0200 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Dactinomycin | GDSC2 | 0.0000 | 0.8000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Dactolisib | GDSC1,GDSC2 | 0.0003 | 0.2500 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Daporinad | GDSC1,GDSC2 | 0.0001 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Dasatinib | GDSC1,GDSC2 | 0.0010 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Dihydrorotenone | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Docetaxel | GDSC1,GDSC2 | 0.0000 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Doramapimod | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Doxorubicin | GDSC1 | 0.0040 | 5.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Eg5_9814 | GDSC2 | 0.0001 | 0.1000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Elephantin | GDSC2 | 0.0200 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Elesclomol | GDSC1 | 0.0008 | 0.2000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Entinostat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Epirubicin | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | ERK_2440 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | ERK_6604 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Erlotinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Etoposide | GDSC1 | 0.0625 | 16.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Fedratinib | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Fludarabine | GDSC2 | 0.0200 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | FMK | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Foretinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Gallibiscoquinazole | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Gefitinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Gemcitabine | GDSC1,GDSC2 | 0.0001 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | glutathione | GDSC2 | 0.6403 | 640.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GNF-2 | GDSC1 | 0.0050 | 1.2800 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK-LSD1 | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK-LSD1-2HCl | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK1059615 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK2110183B | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK2256098C | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK2276186C | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK269962A | GDSC1 | 0.0098 | 5.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK2801 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK2830371 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK2830371A | GDSC2 | 0.0030 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK319347A | GDSC1 | 0.0195 | 5.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK3337463A | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK343 | GDSC2 | 0.0010 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK626616AC | GDSC2 | 0.0001 | 0.1000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | GW843682X | GDSC1 | 0.0010 | 0.2560 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | HKMTI-1-005 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | I-BET-762 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | I-BET151 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | IAP_5620 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | IC-87114 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | ICL-SIRT078 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Idelalisib | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | IGF1R_3801 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Imatinib | GDSC1 | 0.0078 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | IOX2 | GDSC1 | 0.0004 | 0.1000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | IRAK4_4710 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Irinotecan | GDSC2 | 0.0050 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | JAK_8517 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | JAK1_8709 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | JQ1 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | JW-7-52-1 | GDSC1 | 0.0047 | 1.2000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | KU-55933 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | KU-60019 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | L-Oxonoreleagnine | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Lapatinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | LGK974 | GDSC1,GDSC2 | 0.0050 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Linifanib | GDSC1 | 0.0040 | 1.0240 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Linsitinib | GDSC1,GDSC2 | 0.0025 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | LMB_AB1 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | LMB_AB2 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | LMB_AB3 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | LMP744 | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Luminespib | GDSC1,GDSC2 | 0.0003 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | LY2109761 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Masitinib | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Methotrexate | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | MG-132 | GDSC1,GDSC2 | 0.0039 | 4.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | MIM1 | GDSC1,GDSC2 | 0.0100 | 40.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Mitoxantrone | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | MK-1775 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | MK-2206 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Mycophenolic acid | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | N-acetyl cysteine | GDSC2 | 2.0011 | 2000.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | N25720-51-A1 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | N27922-53-1 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | N29087-69-1 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | N30652-18-1 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Navitoclax | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Nelarabine | GDSC2 | 0.0200 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Nilotinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Nutlin-3a | GDSC1,GDSC2 | 0.0080 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | NVP-ADW742 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | NVP-TAE684 | GDSC1 | 0.0078 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Obatoclax Mesylate | GDSC1,GDSC2 | 0.0100 | 16.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Olaparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | OSI-027 | GDSC1,GDSC2 | 0.0040 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | OSI-930 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Oxaliplatin | GDSC2 | 0.0100 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PAC-1 | GDSC1 | 0.0100 | 2.5600 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Paclitaxel | GDSC1,GDSC2 | 0.0000 | 0.1024 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PAK_5339 | GDSC2 | 0.0300 | 30.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Palbociclib | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Panobinostat | GDSC1 | 0.0040 | 1.0240 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Parthenolide | GDSC1 | 0.0195 | 5.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Pazopanib | GDSC1 | 0.0312 | 8.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PBD-288 | GDSC2 | 0.0050 | 5.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PD0325901 | GDSC1,GDSC2 | 0.0003 | 2.5000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PD173074 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Pemetrexed | GDSC1 | 0.0100 | 2.5600 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Pevonedistat | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PF-4708671 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PHA-665752 | GDSC1 | 0.0078 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PHA-793887 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PI-103 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Pictilisib | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PIK-93 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Piperlongumine | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PLX-4720 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Podophyllotoxin bromide | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | POMHEX | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Pyrimethamine | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | QS11 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Quizartinib | GDSC1 | 0.0040 | 1.0240 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Rapamycin | GDSC1,GDSC2 | 0.0000 | 0.1000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Romidepsin | GDSC2 | 0.0000 | 0.0100 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Ruxolitinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | S-Trityl-L-cysteine | GDSC1 | 0.0200 | 5.1200 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Salubrinal | GDSC1 | 0.0625 | 16.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Sapitinib | GDSC2 | 0.0050 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Saracatinib | GDSC1 | 0.0078 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | SB505124 | GDSC1 | 0.0391 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Schweinfurthin A | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Seliciclib | GDSC1 | 0.0625 | 16.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Selisistat | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Selumetinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Sepantronium bromide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Serdemetan | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | SGC-CBP30 | GDSC2 | 0.0050 | 5.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Sinularin | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | SL0101 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | SN-38 | GDSC1,GDSC2 | 0.0000 | 0.1000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | SNX-2112 | GDSC1 | 0.0100 | 2.5600 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Sorafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Sphingosine Kinase 1 Inhibitor II | GDSC1 | 0.0100 | 2.5600 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | SU11274 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Sunitinib | GDSC1 | 0.0312 | 8.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | TAF1_5496 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Tamoxifen | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Tanespimycin | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Taselisib | GDSC2 | 0.0040 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Telomerase Inhibitor IX | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Temozolomide | GDSC1,GDSC2 | 0.0300 | 30.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Teniposide | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | TGX221 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | THR-101 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | THR-102 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | THR-103 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Tivozanib | GDSC1 | 0.0005 | 0.1280 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Topotecan | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Tozasertib | GDSC1 | 0.0078 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | TPCA-1 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Tretinoin | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Tubastatin A | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | TW 37 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Ulixertinib | GDSC2 | 0.0020 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | ULK1_4989 | GDSC2 | 0.0300 | 30.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | UMI-77 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | UNC0379 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | UNC0638 | GDSC1,GDSC2 | 0.0050 | 40.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Veliparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Vinblastine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Vincristine | GDSC2 | 0.0030 | 3.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Vorinostat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | VSP34_8731 | GDSC2 | 0.0300 | 30.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | VTP-A | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | VTP-B | GDSC2 | 0.0010 | 1.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | WH-4-023 | GDSC1 | 0.0200 | 5.1200 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | WZ-1-84 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | XAV939 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | XMD8-85 | GDSC1 | 0.0312 | 8.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | YK-4-279 | GDSC1,GDSC2 | 0.0200 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Z-LLNle-CHO | GDSC1 | 0.0100 | 2.5600 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | Zoledronate | GDSC2 | 0.0020 | 2.0000 |
|
| KS-1[HUMANKRUKENBERGTUMOUR] | ZSTK474 | GDSC1 | 0.0200 | 5.1200 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC